🇺🇸 Continuous Pramlintide infusion in United States

Continuous Pramlintide infusion (Continuous Pramlintide infusion) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Continuous Pramlintide infusion in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Continuous Pramlintide infusion approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Continuous Pramlintide infusion in United States?

University Diabetes & Endocrine Consultants is the originator. The local marketing authorisation holder may differ — check the official source linked above.